The procedure combines stem cells from the patient’s fat and bone marrow, platelet-rich plasma and dextrose prolotherapy, according to a Jan. 4 news release.
Dr. Fields, a licensed sports medicine physician and chiropractor, is offering the stem cell therapy to patients with cartilage damage and those who have had joint replacement recommended.
Although rising in popularity among clinicians, many industry leaders believe there is not a sufficient body of clinical evidence to fully support the safety and efficacy of regenerative therapies in orthopedics.
More articles on biologics:
ISASS updates policy, clinical guidelines on sacroiliac joint fusion
Safe Orthopaedics introduces virtual OR spine surgery tool
Stryker introduces next-gen surgical helmet
